TuisB1AX34 • BVMF
add
Baxter International Inc Bdr
Vorige sluiting
R$105,07
Jaarwisseling
R$85,16 - R$109,24
Markkapitalisasie
17,54 mjd USD
Gemiddelde volume
67,00
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 2,75 mjd | 0,99% |
Bedryfskoste | 844,00 m | 6,84% |
Netto inkomste | -512,00 m | -308,98% |
Netto winsgrens | -18,60 | -306,90% |
Wins per aandeel | 0,58 | -34,09% |
EBITDA | 524,00 m | -10,73% |
Effektiewe belastingkoers | 6,33% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 1,76 mjd | -42,69% |
Totale bates | 25,78 mjd | -8,82% |
Totale aanspreeklikheid | 18,76 mjd | -5,30% |
Totale ekwiteit | 7,02 mjd | — |
Uitstaande aandele | 511,62 m | — |
Prys om te bespreek | 7,71 | — |
Opbrengs op bates | 2,66% | — |
Opbrengs op kapitaal | 3,35% | — |
Kontantvloei
Netto kontantverandering
(USD) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -512,00 m | -308,98% |
Kontant van bedrywe | 488,00 m | -8,10% |
Kontant van beleggings | -205,00 m | 10,87% |
Kontant van finansiering | 141,00 m | 104,80% |
Netto kontantverandering | 334,00 m | 112,88% |
Beskikbare kontantvloei | 590,88 m | 4 580,20% |
Meer oor
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Heathcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Gestig
1931
Hoofkwartier
Webwerf
Werknemers
38 000